<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhang Q</submitter><funding>Guangxi Clinical Research Center for Pediatric Diseases</funding><funding>Guangxi Key Laboratory of Birth Defects and Stem Cell Biobank</funding><funding>Liaoning Province Applied Basic Research Program Project</funding><funding>Guangxi Key Laboratory of reproductive health and birth defect prevention</funding><funding>Guangxi Zhuang Autonomous Region Health Department</funding><funding>Guangxi Zhuang Region Health Department</funding><pagination>116</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12911162</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>26(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Developmental and epileptic encephalopathy-73 (DEE73, OMIM: #618379) is a rare autosomal dominant genetic disorder. This study reports a novel de novo RNF13 variant in a Chinese patient, aiming to assess its pathogenicity and expand understanding of the phenotypic and molecular spectrum of DEE73.&lt;h4>Methods&lt;/h4>Whole-exome sequencing was performed on the patient to identify candidate variants associated with the clinical phenotype. Putative pathogenic variants were validated by Sanger sequencing. In silico prediction tools were used to assess the functional impact of the identified variant. A literature review was conducted to summarize the clinical features of the 7 previously reported cases of DEE73.&lt;h4>Results&lt;/h4>A novel likely pathogenic frameshift variant, c.929del</pubmed_abstract><journal>BMC neurology</journal><pubmed_title>A novel de novo RNF13 variant in developmental and epileptic encephalopathy 73: genotype-phenotype correlation and literature review.</pubmed_title><pmcid>PMC12911162</pmcid><funding_grant_id>21-220-22</funding_grant_id><funding_grant_id>ZTJ2020002</funding_grant_id><funding_grant_id>Guike AD22035121</funding_grant_id><funding_grant_id>Z20220256</funding_grant_id><funding_grant_id>2023JH2/101300044</funding_grant_id><funding_grant_id>Z-A20230305</funding_grant_id><funding_grant_id>Z20190311</funding_grant_id><pubmed_authors>Ruan Y</pubmed_authors><pubmed_authors>Luo J</pubmed_authors><pubmed_authors>Yang Q</pubmed_authors><pubmed_authors>Zhang S</pubmed_authors><pubmed_authors>Zhou X</pubmed_authors><pubmed_authors>Zhang Q</pubmed_authors></additional><is_claimable>false</is_claimable><name>A novel de novo RNF13 variant in developmental and epileptic encephalopathy 73: genotype-phenotype correlation and literature review.</name><description>&lt;h4>Background&lt;/h4>Developmental and epileptic encephalopathy-73 (DEE73, OMIM: #618379) is a rare autosomal dominant genetic disorder. This study reports a novel de novo RNF13 variant in a Chinese patient, aiming to assess its pathogenicity and expand understanding of the phenotypic and molecular spectrum of DEE73.&lt;h4>Methods&lt;/h4>Whole-exome sequencing was performed on the patient to identify candidate variants associated with the clinical phenotype. Putative pathogenic variants were validated by Sanger sequencing. In silico prediction tools were used to assess the functional impact of the identified variant. A literature review was conducted to summarize the clinical features of the 7 previously reported cases of DEE73.&lt;h4>Results&lt;/h4>A novel likely pathogenic frameshift variant, c.929del</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Jan</publication><modification>2026-07-10T03:10:11.317Z</modification><creation>2026-07-10T03:08:20.96Z</creation></dates><accession>S-EPMC12911162</accession><cross_references><pubmed>41578212</pubmed><doi>10.1186/s12883-026-04651-9</doi></cross_references></HashMap>